TRANSCENTA-B: Next Day Disclosure Returns
May 3 09:23 ET
TRANSCENTA-B: Next Day Disclosure Returns
May 2 06:14 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 30 06:53 ET
TRANSCENTA-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Apr 30 04:54 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 30 04:43 ET
TRANSCENTA-B: APPOINTMENT OF A MEMBER OF NOMINATION COMMITTEE AND RESIGNATION OF EXECUTIVE DIRECTOR
Apr 30 04:30 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 26 07:12 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 25 06:58 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 24 07:04 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 23 07:04 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 22 07:37 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 18 07:42 ET
TRANSCENTA-B: NOTIFICATION LETTER AND REPLY FORM TO REGISTERED HOLDERS
Apr 18 04:34 ET
TRANSCENTA-B: 2023 Environmental, Social and Governance Report
Apr 18 04:33 ET
TRANSCENTA-B: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDERS
Apr 18 04:32 ET
TRANSCENTA-B: 2023 ANNUAL REPORT
Apr 18 04:30 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 17 06:45 ET
TRANSCENTA-B: Next Day Disclosure Returns
Apr 16 07:51 ET
TRANSCENTA-B: VOLUNTARY ANNOUNCEMENT-BUSINESS UPDATE ON COLLABORATION WITH AGILENT TO DEVELOP A CLAUDIN18.2 COMPANION DIAGNOSTIC TO SUPPORT OSEMITAMAB (TST001) GLOBAL PHASE III TRIAL
Apr 8 18:39 ET
TRANSCENTA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Apr 5 04:32 ET
No Data
No Data